GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in GH Research PLC as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −5 vs. Q2 2023
- Shares held
- 29.0M
- −630.0K (−2.1%) vs. Q2 2023
- Total value
- $291.5M
- −$60.1M (−17.1%) vs. Q2 2023
- New holders
- 1
- 14 more added
- Sold out
- 6
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 109 | $1.09K | 0.00% | +109 | New |
| Global Retirement Partners, LLC | 220 | $2.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 2,000 | $14.1K | 0.00% | 00.0% | Unchanged |
| Tortoise Investment Management, LLC | 3,081 | $31.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 10,704 | $107.6K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 16,304 | $163.9K | 0.00% | +13,532+488.2% | Added |
| BlackRock Inc. | 24,364 | $244.9K | 0.00% | +9,548+64.4% | Added |
| PEAK6 Investments LLC | 40,308 | $405.1K | 0.02% | +16,991+72.9% | Added |
| Renaissance Technologies LLC | 44,400 | $446.0K | 0.00% | +18,900+74.1% | Added |
| AdvisorShares Investments LLC | 46,323 | $465.5K | 0.12% | +1,194+2.6% | Added |
| Geode Capital Management, LLC | 57,184 | $574.7K | 0.00% | +7,155+14.3% | Added |
| Barclays PLC | 63,590 | $639.1K | 0.00% | +31,500+98.2% | Added |
| Laurion Capital Management LP | 64,930 | $652.5K | 0.02% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 92,784 | $932.5K | 0.00% | +12,911+16.2% | Added |
| Millennium Management LLC | 107,291 | $1.08M | 0.00% | +80,896+306.5% | Added |
| Citadel Advisors LLC | 167,921 | $1.69M | 0.00% | +23,350+16.2% | Added |
| Morgan Stanley | 307,209 | $3.09M | 0.00% | −86,529−22.0% | Reduced |
| 5AM Venture Management, LLC | 404,404 | $4.06M | 1.17% | +252,382+166.0% | Added |
| Deep Track Capital, LP | 499,400 | $5.02M | 0.19% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 593,043 | $5.96M | 0.35% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 1,103,178 | $11.1M | 7.33% | +133,804+13.8% | Added |
| Verition Fund Management LLC | 1,185,238 | $11.9M | 0.16% | +389,066+48.9% | Added |
| VR Adviser, LLC | 2,744,125 | $27.6M | 2.90% | −773,000−22.0% | Reduced |
| FMR LLC | 3,235,469 | $32.5M | 0.00% | −890,996−21.6% | Reduced |
| RTW Investments, LP | 3,327,129 | $33.4M | 0.71% | +1,158,172+53.4% | Added |
| Ra Capital Management, L.P. | 5,587,333 | $56.2M | 1.11% | 00.0% | Unchanged |
| BVF Inc | 9,275,158 | $93.2M | 2.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −736,315−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −244,828−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −12,135−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,641−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −61−100.0% | Sold out |